Small raise for NIH, CDC budgets

The latest proposal for the 2008 budget for the National Institutes of Health and the Centers for Disease Control and Prevention gives the agencies a slight bump over last year's levels. Over the weekend, Congress prepared a new version of appropriations following President George Bush's linkurl:veto;http://www.the-scientist.com/news/display/53858 of previous bill in November. This new bill includes $760 million less for NIH and $240 million less for CDC than the vetoed bill, according to linkur

kerry grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The latest proposal for the 2008 budget for the National Institutes of Health and the Centers for Disease Control and Prevention gives the agencies a slight bump over last year's levels. Over the weekend, Congress prepared a new version of appropriations following President George Bush's linkurl:veto;http://www.the-scientist.com/news/display/53858 of previous bill in November. This new bill includes $760 million less for NIH and $240 million less for CDC than the vetoed bill, according to linkurl:news reports;http://www.washingtonpost.com/wp-dyn/content/article/2007/12/16/AR2007121602016.html today. The result is an increase of less than 1% ($130 million) for the NIH from an FY07 budget of roughly $29 billion, says Nancy Granese, the executive director of the Campaign for Medical Research. (CMR is a lobbying group that represents Research!America. __The Scientist's__ founder Eugene Garfield sits on Research!America's board.). "We're not going to be getting the 6.7% increase the linkurl:research community had hoped for,";http://www.the-scientist.com/blog/display/53973 Granese told __The Scientist__. "We're extremely disappointed." Karl Moeller, the executive director of the Campaign for Public Health, another lobbying group for Research!America, is not as disappointed in the bill, at least as far as CDC funding goes. The bill gives the agency a 2.8% boost from FY07 levels. And while that's not the 6.6% increase that was in the bill Congress passed originally, it's a "huge increase over the president's budget request from February of this year," Moeller told __The Scientist__. Congress will take a few more steps before the bill is sent for the president's approval, and Granese said she expects a final version later this week. She said she expects that the bill will pass Congress, although anti-war Democrats and Republicans opposed to earmarks in the bill could vote against it.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio